Abstract
BackgroundSystemic sclerosis (SSc) is an autoimmune disease and microvasculopathy is its major pathophysiological process. Patients with SSc usually have abnormal immune activation, neovascularization, and vascular remodeling. Progressive fibrosis and dysfunction...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
